Orange Book product · Brand (NDA)
VERDESO
DESONIDE
At a glance
Sep 19, 2006
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 19, 2006
20 yr ago
Today
Patent 8460641 expires
Listed drug product patent expiration.
Aug 13, 2027
in 1 yr 2 mo
Pharmaceutical detail
Active ingredient
DESONIDE
Strength
0.05%
Dosage form
AEROSOL, FOAM
Route
TOPICAL
TE code
Not listed
Application
NDA 021978
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2006DESONATEBrand (NDA)
NDA 021844 · LEO PHARMA AS
- 1984DESOWENBrand (NDA)
NDA 019048 · GALDERMA LABS LP
- —DESONIDEBrand (NDA)
NDA 017010 · PADAGIS US
- —DESONIDEBrand (NDA)
NDA 017426 · PADAGIS US
- 2022DESONIDEGeneric (ANDA)
ANDA 214396 · ALEMBIC
- 2020DESONIDEGeneric (ANDA)
ANDA 213632 · ALEMBIC
- 2020DESONIDEGeneric (ANDA)
ANDA 202470 · SENORES PHARMS
- 2019DESONIDEGeneric (ANDA)
ANDA 210198 · CADILA
- 2019DESONIDEGeneric (ANDA)
ANDA 212473 · ALEMBIC
- 2019DESONIDEGeneric (ANDA)
ANDA 212002 · PAI HOLDINGS PHARM
- 2019DESONIDEGeneric (ANDA)
ANDA 210998 · ENCUBE ETHICALS
- 2017DESONIDEGeneric (ANDA)
ANDA 207855 · ENCUBE
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8460641 | Aug 13, 2027 | in 1 yr 2 mo | ProductU-1412 |

